Frank Biertz

1.2k citations

34 papers · 698 indexed · h-index 15

Pulmonary and Respiratory Medicine top 10%
Cardiology and Cardiovascular Medicine top 10%
Physiology
Epidemiology
Molecular Biology

Co-authors: Claus Vogelmeier Rudolf A. Jörres Robert Bals Sascha David Henrik Watz Peter Alter Kathrin Kahnert Danilo Fliser
Topics: Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers)Respiratory Support and Mechanisms (7 papers)Asthma and respiratory diseases (7 papers)
Cited by: Nephrology Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine
Journals: PLoS ONE American Journal of Respiratory and Critical Care Medicine European Journal of Cancer
Partner nations: Germany Netherlands United States

In The Last Decade

Frank Biertz

32 papers receiving 677 citations

Peers

Countries citing papers authored by Frank Biertz

Since Specialization

Citations

This map shows the geographic impact of Frank Biertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Biertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Biertz more than expected).

Fields of papers citing papers by Frank Biertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Biertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Biertz. The network helps show where Frank Biertz may publish in the future.

Co-authorship network of co-authors of Frank Biertz

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Biertz. A scholar is included among the top collaborators of Frank Biertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Biertz. Frank Biertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET 2024 ·Respirology ·(unknown),(unknown),Swetlana Gaffron,Roman Martin,Dieter Maier,Peter Alter,Frank Biertz,(unknown),Wilhelm Bertrams,Anna Lena Jung,(unknown),Dominik Heider,Miel Wouters,Claus Vogelmeier,Bernd Schmeck,(unknown)	1
2	Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD 2019 ·Respiratory Research ·Peter Alter,Henrik Watz,Kathrin Kahnert,Klaus F. Rabe,Frank Biertz,R. Fischer,(unknown),(unknown),Robert Bals,Claus Vogelmeier,Rudolf A. Jörres	13
3	Time-updated resting heart rate predicts mortality in patients with COPD 2019 ·Clinical Research in Cardiology ·(unknown),Albert Omlor,Franziska Trudzinski,(unknown),Frederik Seiler,Frank Biertz,Claus Vogelmeier,Tobias Welte,Henrik Watz,Benjamin Waschki,Titus J. Brinker,Stefan Andreas,Sebastian Fähndrich,Peter Alter,Rudolf A. Jörres,Michael Böhm,Robert Bals	9
4	<p>Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort</p> 2019 ·Patient Preference and Adherence ·(unknown),Rudolf A. Jörres,Sandra Söhler,Tobias Welte,Jürgen Behr,Joachim H. Ficker,Robert Bals,Henrik Watz,Johanna I. Lutter,(unknown),Frank Biertz,Peter Alter,Claus Vogelmeier,Kathrin Kahnert	7
5	Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort 2019 ·Franziska Trudzinski,Kathrin Kahnert,Claus Vogelmeier,Peter Alter,Frederik Seiler,Sebastian Fähndrich,(unknown),Tobias Welte,(unknown),Stephen Zewinger,Frank Biertz,Hans‐Ulrich Kauczor,(unknown),Robert Bals	0
6	Genome-Wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development 2018 ·Genomics Proteomics & Bioinformatics ·Andreas Keller,Tobias Fehlmann,Nicole Ludwig,Mustafa Kahraman,Thomas Laufer,Christina Backes,Claus Vogelmeier,Caroline Diener,Frank Biertz,Christian Herr,Rudolf A. Jörres,Hans‐Peter Lenhof,Eckart Meese,Robert Bals,(unknown)	30
7	Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach 2018 ·Respiratory Research ·Kathrin Kahnert,Peter Alter,Tobias Welte,Rudolf M. Huber,Jürgen Behr,Frank Biertz,Henrik Watz,Robert Bals,Claus Vogelmeier,Rudolf A. Jörres	33
8	The revised GOLD 2017 COPD categorization in relation to comorbidities 2018 ·Pneumologie ·Kathrin Kahnert,Peter Alter,(unknown),(unknown),Joachim Heinrich,(unknown),Jürgen Behr,Margarethe Wacker,Frank Biertz,Henrik Watz,Robert Bals,Tobias Welte,Hubert Wirtz,Felix Herth,Jørgen Vestbo,E.F.M. Wouters,Claus Vogelmeier,RA Jörres	1
9	Comorbidity Patterns In Alpha-1-Antitrypsin Deficiency Depend On Natural History And Substitution Therapy 2017 ·American Journal of Respiratory and Critical Care Medicine ·Sebastian Fähndrich,Frank Biertz,Annika Karch,(unknown),Alvaro Koch,(unknown),Tobias Welte,Timm Greulich,Hans‐Ulrich Kauczor,Sabina Janciauskiene,Rudolf A. Jörres,C. Franz Vogelmeier,Robert Bals	1
10	Cardiovascular risk in patients with alpha-1-antitrypsin deficiency 2017 ·Respiratory Research ·(unknown),Sebastian Fähndrich,Frank Biertz,Annika Karch,(unknown),Armin Koch,Helmut Teschler,Tobias Welte,Hans‐Ulrich Kauczor,Sabina Janciauskiene,Rudolf A. Jörres,Timm Greulich,Claus Vogelmeier,Robert Bals	28
11	The revised GOLD 2017 COPD categorization in relation to comorbidities 2017 ·Respiratory Medicine ·Kathrin Kahnert,Peter Alter,David Young,(unknown),Joachim Heinrich,Rudolf M. Huber,Jürgen Behr,Margarethe Wacker,Frank Biertz,Henrik Watz,Robert Bals,Tobias Welte,(unknown),Felix Herth,Jørgen Vestbo,Emiel F.�M. Wouters,Claus Vogelmeier,Rudolf A. Jörres	35
12	Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort 2017 ·Respiratory Research ·(unknown),Kathrin Kahnert,(unknown),Frank Biertz,Andreas Lechner,Henrik Watz,Peter Alter,Robert Bals,Jürgen Behr,Rolf Holle,Rudolf M. Huber,Stefan Karrasch,Beate Stubbe,Margarethe Wacker,Sandra Söhler,Emiel F.�M. Wouters,Claus Vogelmeier,Rudolf A. Jörres	14
13	Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort 2017 ·Epidemiology ·Kathrin Kahnert,(unknown),Rudolf M. Huber,Jürgen Behr,Frank Biertz,Anja Vogt,Henrik Watz,Peter Alter,Sebastian Fähndrich,Robert Bals,Rolf Holle,Stefan Karrasch,Sandra Söhler,Margarethe Wacker,Joachim H. Ficker,Klaus G. Parhofer,Claus Vogelmeier,Rudolf A. Jörres	6
14	Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication 2016 ·PLoS ONE ·(unknown),(unknown),Margarethe Wacker,Rolf Holle,Frank Biertz,Dennis Nowak,Rudolf M. Huber,Sandra Söhler,Claus Vogelmeier,Joachim H. Ficker,Harald Mückter,Rudolf A. Jörres	33
15	Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial 2012 ·Trials ·Lena Schiffer,Mario Schiffer,Saskia Merkel,Anke Schwarz,Michael Mengel,(unknown),Christoph Schroeder,Alexander A. Zoerner,(unknown),Verena Bröcker,Jan U. Becker,(unknown),(unknown),Anika Großhennig,Frank Biertz,Hermann Haller,Armin Koch,Wilfried Gwinner	1
16	A Survey to Assess Family Physicians’ Motivation to Teach Undergraduates in Their Practices 2012 ·PLoS ONE ·Marcus May,(unknown),Frank Biertz,Eva Hummers,Carsten Kruschinski	34
17	Long-term persistence of MRSA in re-admitted patients 2010 ·Infection ·Frauke Mattner,Frank Biertz,Stefan Ziesing,Petra Gastmeier,Iris F. Chaberny	30
18	Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis 2009 ·Critical Care ·Philipp Kümpers,Matijs van Meurs,Sascha David,Grietje Molema,Johan Bijzet,Alexander Lukasz,Frank Biertz,Hermann Haller,Jan G. Zijlstra	85
19	Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis 2007 ·Nephrology Dialysis Transplantation ·Sascha David,P. Kumpers,(unknown),Frank Biertz,Hermann Haller,Danilo Fliser	82
20	Adverse Effects of Rabies Pre- and Postexposure Prophylaxis in 290 Health-Care-Workers Exposed to a Rabies Infected Organ Donor or Transplant Recipients 2007 ·Infection ·Frauke Mattner,(unknown),(unknown),(unknown),Sabine Kühn,Petra Gastmeier,Lutz Mattner,Frank Biertz,Albert Heim,Cornelia Henke‐Gendo,Ilka Engelmann,Andreas Martens,M. Strüber,Thomas F. Schulz	11

About Frank Biertz

Frank Biertz is a scholar working on Issues, ethics and legal aspects, Pulmonary and Respiratory Medicine and Family Practice, having authored 34 papers that have together received 698 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Respiratory Support and Mechanisms (7 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Nephrology (90 citations), Pulmonary and Respiratory Medicine (338 citations) and Cardiology and Cardiovascular Medicine (152 citations). Frank Biertz has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Claus Vogelmeier, Rudolf A. Jörres, Robert Bals, Sascha David, Henrik Watz, Peter Alter, Kathrin Kahnert, Danilo Fliser, P. Kumpers and Hermann Haller. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact